New eye drug shows promise for Diabetes-Related vision loss

NCT ID NCT06847854

Ongoing Disease control Sponsor: Genentech, Inc. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 24 times

Summary

This early-stage study tests a new medicine called RO7497372 for people with diabetic macular edema, a condition that causes vision loss. The study involves 151 participants and checks if the drug is safe and how it works in the body. The medicine is given as an injection into the eye, and the study has two parts to find the right dose.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Arkansas Retina Research

Little Rock, Arkansas, 72205, United States
Associated Retina Consultants

Phoenix, Arizona, 85020, United States
Austin Clinical Research LLC

Austin, Texas, 78750, United States
Barnet Dulaney Perkins Eye Center

Mesa, Arizona, 85206, United States
Bay Area Retina Associates

Walnut Creek, California, 94598, United States
Brown Retina Institute

Schertz, Texas, 78154, United States
Carolina Eyecare Physicians

Mt. Pleasant, South Carolina, 29464, United States
Center for Retina and Macula Disease

Winter Haven, Florida, 33880, United States
Charles Retina Institute

Germantown, Tennessee, 38138, United States
Cleveland Clinic

Cleveland, Ohio, 44106, United States
Cumberland Valley Retina PC

Hagerstown, Maryland, 21740, United States
East Florida Eye Institute

Stuart, Florida, 34994, United States
Emanuelli Research and Development Center

Arecibo, 00612, Puerto Rico
Emerson Clinical Research Institute

Falls Church, Virginia, 78503, United States
Erie Retinal Surgery

Erie, Pennsylvania, 16507, United States
EyeHealth Northwest

Portland, Oregon, 97225, United States
Florida Eye Associates

Melbourne, Florida, 32901, United States
Foundation for Vision Research

Grand Rapids, Michigan, 49546, United States
Global Research Management

Glendale, California, 91204, United States
Medeye Associates

Miami, Florida, 33143, United States
Mid Atlantic Retina

Philadelphia, Pennsylvania, 19107, United States
Mississippi Retina Associates

Madison, Mississippi, 39202, United States
Piedmont Eye Center

Lynchburg, Virginia, 24502, United States
Retina Associates of Michigan

Grand Blanc, Michigan, 48439-8301, United States
Retina Associates of NY

New York, New York, 10075, United States
Retina Consultants Minnesota

Saint Louis Park, Minnesota, 55416, United States
Retina Consultants of Texas

The Woodlands, Texas, 77384, United States
Retina Group of Washington

Fairfax, Virginia, 20815, United States
Retina Specialists of Tampa

Wesley Chapel, Florida, 33544, United States
Retinal Consultants Medical Group

Modesto, California, 95356, United States
Retinal Consultants of AZ, Ltd

Peoria, Arizona, 85381, United States
Ross Eye Institute

Buffalo, New York, 14209-2102, United States
Salt Lake Retina

West Jordan, Utah, 84088, United States
Sierra Eye Associates

Reno, Nevada, 89502, United States
Spokane Eye Clinical Research

Spokane, Washington, 99204-2509, United States
The Retina Institute

St Louis, Missouri, 63128, United States
Verum Research LLC

Eugene, Oregon, 97401, United States
Wagner Kapoor Institute

Norfolk, Virginia, 23502, United States

Conditions

Explore the condition pages connected to this study.

DIABETIC MACULAR EDEMA